The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-{[7-Chloro-3-methyl-4-oxo-2-(4-phenyl-piperazin-1-ylmethyl)-3,4-dihydro-quinazolin-6-ylmethyl]-prop-2-ynyl-amino}-N-pyridin-3-ylmethyl-benzamide ID: ALA122748
PubChem CID: 11828408
Max Phase: Preclinical
Molecular Formula: C37H36ClN7O2
Molecular Weight: 646.20
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C#CCN(Cc1cc2c(=O)n(C)c(CN3CCN(c4ccccc4)CC3)nc2cc1Cl)c1ccc(C(=O)NCc2cccnc2)cc1
Standard InChI: InChI=1S/C37H36ClN7O2/c1-3-16-45(31-13-11-28(12-14-31)36(46)40-24-27-8-7-15-39-23-27)25-29-21-32-34(22-33(29)38)41-35(42(2)37(32)47)26-43-17-19-44(20-18-43)30-9-5-4-6-10-30/h1,4-15,21-23H,16-20,24-26H2,2H3,(H,40,46)
Standard InChI Key: BWXHDEQBNGJGJX-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 52 0 0 0 0 0 0 0 0999 V2000
-1.1333 -2.0750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4250 -1.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1333 -2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2875 -2.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4250 -3.3042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2875 -2.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7042 -2.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9917 -1.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8458 -5.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0000 -3.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4292 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7125 -2.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8500 -4.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4167 -1.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8500 -3.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -2.0667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8417 -0.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5500 -0.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1417 -1.6417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4250 -0.8292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6042 -2.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9625 -2.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5625 -5.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1333 -5.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8500 -6.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6417 -2.8542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2625 -0.3875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1917 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1875 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3667 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3667 -1.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5667 -1.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1333 -4.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5583 -4.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8542 -2.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8500 -1.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4250 -3.3042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.1292 -1.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5542 -0.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9875 -0.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5708 -7.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1375 -7.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2792 -2.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9917 -1.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1375 -7.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5708 -7.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8583 -8.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 1 0
5 3 2 0
6 5 1 0
7 8 1 0
8 4 2 0
9 23 1 0
10 6 2 0
11 21 1 0
12 10 1 0
13 15 1 0
14 7 1 0
15 3 1 0
16 14 1 0
17 38 1 0
18 17 3 0
19 11 1 0
20 2 2 0
21 29 1 0
22 16 1 0
23 34 1 0
24 33 1 0
25 9 1 0
26 11 2 0
27 39 2 0
28 30 1 0
29 31 2 0
30 22 2 0
31 22 1 0
32 35 1 0
33 13 1 0
34 13 1 0
35 19 1 0
36 1 1 0
37 12 1 0
38 16 1 0
39 32 1 0
40 44 2 0
41 25 2 0
42 25 1 0
43 32 2 0
44 43 1 0
45 42 2 0
46 41 1 0
47 45 1 0
6 4 1 0
24 9 1 0
12 7 2 0
21 28 2 0
47 46 2 0
40 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 646.20Molecular Weight (Monoisotopic): 645.2619AlogP: 4.87#Rotatable Bonds: 10Polar Surface Area: 86.60Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.83CX LogP: 4.87CX LogD: 4.86Aromatic Rings: 5Heavy Atoms: 47QED Weighted: 0.22Np Likeness Score: -1.79
References 1. Bavetsias V, Skelton LA, Yafai F, Mitchell F, Wilson SC, Allan B, Jackman AL.. (2002) The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent., 45 (17): [PMID:12166942 ] [10.1021/jm011081s ]